Zebra Capital Management LLC Chemo Centryx, Inc. Transaction History

Zebra Capital Management LLC

$20 Million
Q1 2023

Shares

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2019 Nov 14, 2019	SELL	$6.47 - $8.96 $71,965 - $99,662	-11,123 Closed	0 $0
Q2 2019 Aug 14, 2019	SELL	$8.31 - $14.85 $14,376 - $25,690	-1,730 Reduced 13.46%	11,123 $103,000
Q1 2019 May 15, 2019	SELL	$10.01 - $13.89 $15,445 - $21,432	-1,543 Reduced 10.72%	12,853 $179,000
Q4 2018 Feb 14, 2019	BUY	$9.15 - $12.26 $131,723 - $176,494	14,396 New	14,396 $157,000

Others Institutions Holding CCXI

# of Institutions

6

Shares Held

66.3K

Call Options Held

0

Put Options Held

0

About ChemoCentryx, Inc.

Ticker CCXI
Exchange NASDAQ
Shares Outstandng 71,919,696
Market Cap $3.68M
Description
ChemoCentryx, Inc., a biopharmaceutical company, focuses on the development and commercialization of new medications for inflammatory disorders, autoimmune diseases, and cancer in the United States. It offers TAVNEOS (avacopan), an orally administered selective C5aR inhibitor for the treatment of adult patients with severe active anti-neutrophil...

More about CCXI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zebra Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Zebra Capital Management LLC with notifications on news.